Toll Free: 1-888-928-9744

Handok Inc. - Product Pipeline Review - 2014

Published: May, 2014 | Pages: 37 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Handok Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Handok Inc. - Product Pipeline Review - 2014', provides an overview of the Handok Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Handok Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Handok Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Handok Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Handok Inc.'s pipeline products

Reasons to buy

- Evaluate Handok Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Handok Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Handok Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Handok Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Handok Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Handok Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Handok Inc. Snapshot 5
Handok Inc. Overview 5
Key Information 5
Key Facts 5
Handok Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Handok Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Handok Inc. - Pipeline Products Glance 12
Handok Inc. - Late Stage Pipeline Products 12
Pre-Registration Products/Combination Treatment Modalities 12
Handok Inc. - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Handok Inc. - Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
Handok Inc. - Drug Profiles 17
teneligliptin 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
ozarelix 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
HL-1513 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
HL-2351 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
HL-2353 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
HL-5201 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
HL-5501 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
HL-3501 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
HL-5171 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
HL-5511 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Handok Inc. - Pipeline Analysis 29
Handok Inc. - Pipeline Products by Target 29
Handok Inc. - Pipeline Products by Route of Administration 30
Handok Inc. - Pipeline Products by Molecule Type 31
Handok Inc. - Pipeline Products by Mechanism of Action 32
Handok Inc. - Recent Pipeline Updates 33
Handok Inc. - Dormant Projects 34
Handok Inc. - Locations And Subsidiaries 35
Head Office 35
Appendix 36
Methodology 36
Coverage 36
Secondary Research 36
Primary Research 36
Expert Panel Validation 36
Contact Us 37
Disclaimer 37
List of Tables
Handok Inc., Key Information 5
Handok Inc., Key Facts 5
Handok Inc. - Pipeline by Indication, 2014 7
Handok Inc. - Pipeline by Stage of Development, 2014 8
Handok Inc. - Monotherapy Products in Pipeline, 2014 9
Handok Inc. - Partnered Products in Pipeline, 2014 10
Handok Inc. - Partnered Products/ Combination Treatment Modalities, 2014 11
Handok Inc. - Pre-Registration, 2014 12
Handok Inc. - Phase II, 2014 13
Handok Inc. - Phase I, 2014 14
Handok Inc. - Preclinical, 2014 15
Handok Inc. - Discovery, 2014 16
Handok Inc. - Pipeline by Target, 2014 29
Handok Inc. - Pipeline by Route of Administration, 2014 30
Handok Inc. - Pipeline by Molecule Type, 2014 31
Handok Inc. - Pipeline Products by Mechanism of Action, 2014 32
Handok Inc. - Recent Pipeline Updates, 2014 33
Handok Inc. - Dormant Developmental Projects,2014 34 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify